Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. 1998

T W Hesterberg, and G Chase, and C Axten, and W C Miller, and R P Musselman, and O Kamstrup, and J Hadley, and C Morscheidt, and D M Bernstein, and P Thevenaz
Johns Manville Corporation, Littleton, Colorado 80162-5005, USA.

Fiber biopersistence as a major mechanism of fiber-induced pathogenicity was investigated. The lung biopersistence of 5 synthetic vitreous fibers (SVFs) and amosite asbestos was evaluated using the rat inhalation model. In contrast to several previous studies, this study examined fibers that dissolve relatively slowly in vitro at pH 7.4. Fisher rats were exposed for 5 days by nose-only inhalation to refractory ceramic fiber (RCF1a), rock (stone) wool (MMVF21), 2 relatively durable special application fiber glasses (MMVF32 or MMVF33), HT stonewool (MMVF34), amosite asbestos, or filtered air. Lung burdens were analyzed during 1 year post-exposure. Fiber aerosols contained 150-230 fibers/cc longer than 20 micrometer (>20 micrometer). On post-exposure Day 1, long-fiber lung burdens for the 6 test fibers were similar (12-16 x 10(5) fibers/lung >20 micrometer). After 1 year, the percentage of fibers >20 micrometer remaining in the lung was 0.04-10% for SVFs but 27% for amosite. Lung clearance weighted half-times (WT1/2) for fibers >20 micrometer were 6 days for MMVF34, 50-80 days for the other 4 SVFs, and >400 days for amosite. This study and 3 previous studies demonstrate a broad range of biopersistences for 19 different SVFs and 2 asbestos types. Ten of these fibers also have been (or are being) tested in chronic inhalation studies; in these studies, the very biopersistent fibers were carcinogenic (amosite, crocidolite, RCF1, MMVF32, and MMVF33), while the more rapidly clearing fibers were not (MMVF10, 11, 21, 22, and 34). These studies demonstrate the importance of biopersistence as an indicator of the potential pathogenicity of a wide range of fiber types.

UI MeSH Term Description Entries
D007616 Kaolin The most common mineral of a group of hydrated aluminum silicates, approximately H2Al2Si2O8-H2O. It is prepared for pharmaceutical and medicinal purposes by levigating with water to remove sand, etc. (From Merck Index, 11th ed) The name is derived from Kao-ling (Chinese: "high ridge"), the original site. (From Grant & Hackh's Chemical Dictionary, 5th ed) Kaolinite
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D005898 Glass Hard, amorphous, brittle, inorganic, usually transparent, polymerous silicate of basic oxides, usually potassium or sodium. It is used in the form of hard sheets, vessels, tubing, fibers, ceramics, beads, etc.
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

T W Hesterberg, and G Chase, and C Axten, and W C Miller, and R P Musselman, and O Kamstrup, and J Hadley, and C Morscheidt, and D M Bernstein, and P Thevenaz
February 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology,
T W Hesterberg, and G Chase, and C Axten, and W C Miller, and R P Musselman, and O Kamstrup, and J Hadley, and C Morscheidt, and D M Bernstein, and P Thevenaz
November 2003, Inhalation toxicology,
T W Hesterberg, and G Chase, and C Axten, and W C Miller, and R P Musselman, and O Kamstrup, and J Hadley, and C Morscheidt, and D M Bernstein, and P Thevenaz
January 2004, Inhalation toxicology,
T W Hesterberg, and G Chase, and C Axten, and W C Miller, and R P Musselman, and O Kamstrup, and J Hadley, and C Morscheidt, and D M Bernstein, and P Thevenaz
May 1999, Environmental health perspectives,
T W Hesterberg, and G Chase, and C Axten, and W C Miller, and R P Musselman, and O Kamstrup, and J Hadley, and C Morscheidt, and D M Bernstein, and P Thevenaz
January 2000, Inhalation toxicology,
T W Hesterberg, and G Chase, and C Axten, and W C Miller, and R P Musselman, and O Kamstrup, and J Hadley, and C Morscheidt, and D M Bernstein, and P Thevenaz
December 1994, Regulatory toxicology and pharmacology : RTP,
T W Hesterberg, and G Chase, and C Axten, and W C Miller, and R P Musselman, and O Kamstrup, and J Hadley, and C Morscheidt, and D M Bernstein, and P Thevenaz
October 1994, Environmental health perspectives,
T W Hesterberg, and G Chase, and C Axten, and W C Miller, and R P Musselman, and O Kamstrup, and J Hadley, and C Morscheidt, and D M Bernstein, and P Thevenaz
October 1994, Environmental health perspectives,
T W Hesterberg, and G Chase, and C Axten, and W C Miller, and R P Musselman, and O Kamstrup, and J Hadley, and C Morscheidt, and D M Bernstein, and P Thevenaz
June 2002, Regulatory toxicology and pharmacology : RTP,
T W Hesterberg, and G Chase, and C Axten, and W C Miller, and R P Musselman, and O Kamstrup, and J Hadley, and C Morscheidt, and D M Bernstein, and P Thevenaz
July 1989, Toxicology,
Copied contents to your clipboard!